Integer's RadialSeal Introducer Kit Receives FDA and CE Mark Approvals
July 31, 2018—Integer Holdings Corporation, an outsource manufacturer, announced that it has received United States FDA and European CE Mark approvals for the RadialSeal radial access introducer. Integer's portfolio of access devices is available for distribution by medical device companies in the interventional cardiology and peripheral vascular markets.
According to the company, the RadialSeal introducer kit is founded on Integer's core technology platforms in guidewires and hemostatic introducers. The RadialSeal features a thin-walled sheath design that minimizes outer diameter while maximizing inner diameter and provided ease of sheath insertion through smooth transitions and a hydrophilic coating.
advertisement
Featured Video
Fight Severe Coronary Calcium
Sponsored by Cardiovascular Systems Inc.
Related Articles
Beyond Radial: Ulnar, Snuffbox, and Palmar Branch Access
A review of the limitations of transradial access and the benefits and challenges of alternative approaches for cardiac catheterization.
By Karim M. Al-Azizi, MD; and Amir S. Lotfi, MD
Navigating Complex Radial Loops
An overview on radial loops and the techniques to circumvent them.
By Shing-Chiu Wong, MD; and Salil Desai, MD
Radial Access Best Practices in 2019
An update on procedural considerations for transradial artery access based on the most recent data.
By Linda M. Koshy, MD; Matthew Schoenfeld, MD; and Binita Shah, MD, MS
Top 5 Articles From June 2018
Patent Foramen Ovale Closure: What Are the Indications?
A summary of lessons learned from positive randomized trial data.
By Mohammad K. Mojadidi, MD; Muhammad O. Zaman, MD; Islam Y. Elgendy, MD, FACP, FESC; Ahmed N. Mahmoud, MD; and Jonathan M. Tobis, MD, FACC, MSCAI
Essentials for a CHIP Program
A comprehensive CHIP program requires a true heart team approach, specialized operator skills and training, and institutional support and resources.
By Justin Levisay, MD
Chronic Total Occlusions: What Is Clear and What Is Controversial?
With improvements in technique and patient selection, operators can safely and successfully treat patients with chronic total occlusions, but further research is needed to better answer some areas of controversy.
By Megha Prasad, MD; and Jeffrey W. Moses, MD
Developing an Ambulatory Strategy
A Q&A on the importance of considering an ambulatory surgical center or office-based lab to achieve your goals.
With Anne Beekman, RN; Jacob Turmell, DNP, RN, NP-C, ACNS-BC, CCRN-CMC; and Marc Toth, CMAA
The Spectrum of Devices for Percutaneous Left Atrial Appendage Occlusion
A look at current and emerging nonpharmacologic stroke prevention therapies.
By Lluis Asmarats, MD; and Josep Rodés-Cabau, MD
Top 5 from EVToday's Current Issue
Roundtable Discussion: Percutaneous AVF Creation in Practice
A multidisciplinary discussion on patient selection, achieving proficiency, procedural tips, and the importance of collaboration.
With John E. Aruny, MD; William C. Jennings, MD, FACS; Charmaine E. Lok, MD; and Aris Urbanes, MD
Understanding Benefits and Risks of Drug-Eluting Stents
Ongoing clinical studies will shed light on patient outcomes in real-world settings.
By Ian T. Meredith, MBBS, PhD, AM
Evaluation and Management of Chronic Thoracic Venous Obstructions
Clinical presentation, anatomic patterns of TCVO, and revascularization strategies.
By Brian Holly, MD; and Mark L. Lessne, MD
AV Access Covered Stent Clinical Trials: A Comparative Review
A status overview of six major clinical trials evaluating the use of covered stents in AV access treatment.
